Distinguishing neurosarcoidosis from multiple sclerosis based on cerebrospinal fluid analysis: A retrospective cohort study

Distinguishing neurosarcoidosis from multiple sclerosis based on cerebrospinal fluid analysis: A retrospective cohort study

Bibliographic Details
Main Authors:	Arun, T, Pattison, L, Palace, J
Format:	Conference item
Language:	English
Published:	BMJ 2019

Similar Items

Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study
by: Arun, T, et al.
Published: (2020)

The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.
by: Moulin, D, et al.
Published: (1983)

ALKALINE ISOELECTRIC-FOCUSING IN POLYACRYLAMIDE-GEL OF CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS
by: Ebers, G, et al.
Published: (1979)

Alkaline isoelectric focusing in polyacrylamide gel of cerebrospinal fluid in multiple sclerosis.
by: Ebers, G, et al.
Published: (1979)

ANTIIDIOTYPIC SERA IN THE STUDY OF CEREBROSPINAL-FLUID IGG BANDS IN MULTIPLE-SCLEROSIS
by: Ebers, G
Published: (1979)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
by: Probert, F, et al.
Published: (2021)

Chronic cerebrospinal venous insufficiency and multiple sclerosis.
by: Handel, A, et al.
Published: (2010)

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
by: Thompson, A, et al.
Published: (2018)

Cerebrospinal fluid biomarker development in amyotrophic lateral sclerosis
by: Thompson, AG
Published: (2018)

Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children
by: Njunge, J, et al.
Published: (2017)

Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children
by: Njunge, J, et al.
Published: (2017)

Anti-idiotypic sera in the study of cerebrospinal fluid IgG bands in multiple sclerosis.
by: Ebers, G
Published: (1979)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.
by: Gray, E, et al.
Published: (2015)

Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients.
by: Bellamy, A, et al.
Published: (1986)

Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients : early involvement in compartmentalised intrathecal inflammation
by: Magliozzi, Roberta, et al.
Published: (2021)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
by: Pace, S, et al.
Published: (2021)

A rare case of disseminated sarcoidosis presenting with neurosarcoidosis: a case report
by: Abdul Sukur, Noorhafini, et al.
Published: (2020)

Ventral subpial and central cord enhancement in spinal neurosarcoidosis: the reverse trident sign
by: Irani, S
Published: (2025)

Analysis of the Cerebrospinal Fluid Flow in the Stenosed Aqueduct of Sylvius
by: H, Edi Azali, et al.
Published: (2011)

Molecular mechanisms of cerebrospinal fluid production.
by: Brown, P, et al.
Published: (2004)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
by: Matthews, L, et al.
Published: (2012)

Making the diagnosis of multiple sclerosis.
by: Palace, J
Published: (2001)

Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
by: Cao, Y., et al.
Published: (2017)

Optimisation of ExoCounter technology for use in cerebrospinal fluid and investigation of placenta-derived exosomes within cerebrospinal fluid
by: Davies, B
Published: (2023)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
by: Arun, T, et al.
Published: (2009)

Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: Interventional procedures guidance [IPG640]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2019)

A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
by: Yeo, T, et al.
Published: (2020)

The UK Multiple Sclerosis database.
by: Palace, J, et al.
Published: (1999)

Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis
by: Dellar, ER, et al.
Published: (2023)

New and old treatments for multiple sclerosis.
by: Palace, J
Published: (1998)

Parameter estimations for the cerebrospinal fluid infusion test
by: Eisentrager, A, et al.
Published: (2013)

Parameter estimations for cerebrospinal fluid infusion test
by: Eisentraeger, A, et al.
Published: (2011)

Making things right : retrospective honours for distinguished acts
by: Chan, Samuel
Published: (2012)

Molecular typing of bacteria directly from cerebrospinal fluid.
by: Enright, M, et al.
Published: (2000)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
by: Wakerley, B, et al.
Published: (2011)

Modifying disability in progressive multiple sclerosis.
by: Palace, J, et al.
Published: (2014)

Modifying disability in progressive multiple sclerosis
by: Palace, J, et al.
Published: (2014)

New treatments and azathioprine in multiple sclerosis.
by: Palace, J, et al.
Published: (1997)

Guidelines for differential diagnosis of suspected multiple sclerosis.
by: Palace, J
Published: (2009)